Non-Current Liabilities
Operating Lease Liability Payments - 2027 (Lessee)
Neurocrine Biosciences Operating Lease Liability Payments - 2027 (Lessee) decreased by 0.7% to $59.80M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 1.5%, from $60.70M to $59.80M.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Liabilities
First reportedQ2 2020
Last reportedQ1 2026May 5, 2026
Metric ID:
lease_liability_payments_2027_lesseeHistorical Data
15 periods
| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $17.00M | $17.00M | $15.90M | $15.90M | $15.90M | $15.70M | $15.70M | $15.70M | $34.80M | $35.80M | $35.80M | $60.70M | $60.70M | $60.20M | $59.80M |
| QoQ Change | — | +0.0% | -6.5% | +0.0% | +0.0% | -1.3% | +0.0% | +0.0% | +121.7% | +2.9% | +0.0% | +69.6% | +0.0% | -0.8% | -0.7% |
| YoY Change | — | — | — | -6.5% | -6.5% | -1.3% | -1.3% | -1.3% | +121.7% | +128.0% | +128.0% | +74.4% | +69.6% | +68.2% | -1.5% |
Range$15.70M – $60.70M
CAGR+43.2%
Avg YoY Growth+47.6%
Median YoY Growth+33.4%
Current Streak2 quarters decline
Operating Lease Liability Payments - 2027 (Lessee) at Other Companies
Frequently Asked Questions
- What is Neurocrine Biosciences's operating lease liability payments - 2027 (lessee)?
- Neurocrine Biosciences (NBIX) reported operating lease liability payments - 2027 (lessee) of $59.80M in Q1 2026.
- How has Neurocrine Biosciences's operating lease liability payments - 2027 (lessee) changed year-over-year?
- Neurocrine Biosciences's operating lease liability payments - 2027 (lessee) decreased by 1.5% year-over-year, from $60.70M to $59.80M.